NCT04619680: An ongoing trial by Icahn School of Medicine at Mount Sinai
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 1 month from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04619680 |
|---|---|
| Title | Early Nintedanib Deployment in COVID-19 Interstitial Lung Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 18, 2020 |
| Completion date | Feb. 1, 2024 |
| Required reporting date | Feb. 1, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |